Structure Therapeutics In... (GPCR)

NASDAQ: GPCR · Real-Time Price · USD

27.09

-0.24 (-0.88%)

At close: May 02, 2025, 3:59 PM

27.93

3.10%

After-hours: May 02, 2025, 05:42 PM EDT

Structure Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Net Income	-36.48M	-33.98M	-26.03M	-25.99M	-24.67M	-23.86M	-23.28M	-17.98M	-11.88M	-12.42M	-13.95M	-13.08M	-13.36K
Depreciation & Amortization	273K	265K	231.74K	658.93K	280.92K	79K	74K	70K	72K	76K	59K	70K	66.00
Stock-Based Compensation	5.83M	6.02M	4.2M	2.74M	2.1M	1.86M	1.7M	2.53M	623K	628K	643K	620K	937.00
Other Working Capital	-111K	3.89M	2.35M	-9.97M	1.34M	5.13M	5.12M	-3.75M	-320K	-846K	1.61M	371K	439.00
Other Non-Cash Items	-5.56M	-2.2M	-2.75M	-1.03M	-1.08M	276K	88K	-262K	-812K	93K	96K	65K	65.00
Deferred Income Tax	n/a	n/a	n/a	n/a	-1.27M	-1.66M	-1.64M	n/a	410K	-280K	-130K	6.01K	4.00
Change in Working Capital	-534K	10.19M	-2.03M	-8.16M	2.73M	2.75M	6.17M	-4.67M	-444K	1.42M	3.19M	-1.19M	1.52K
Operating Cash Flow	-36.47M	-19.7M	-26.39M	-34.02M	-21.91M	-20.56M	-16.89M	-20.31M	-12.03M	-10.48M	-10.1M	-13.52M	-10.76K
Capital Expenditures	-16K	-685K	-427K	-161.74K	-1.16M	-820K	-191K	n/a	-71K	-72K	53K	-65K	-120
Cash Acquisitions	n/a	n/a	n/a	n/a	-37.57K	-30.95K	68.52K	n/a	-10.41K	16.59K	16.13K	n/a	n/a
Purchase of Investments	-132.25M	-255.18M	-283.22M	-31.87M	-237.01M	-14.93M	24.26M	-190.1M	-9.19M	-45.98M	-26.63M	-41.65M	n/a
Sales Maturities Of Investments	165.5M	66.55M	79.4M	33.45M	57.28M	45.88M	-92.78M	141.08M	19.6M	29.4M	10.5M	2M	1.2K
Other Investing Acitivies	n/a	275.07K	-275.06K	1.58K	-1	30.95K	-68.52K	-49.02K	10.41K	-16.59K	-16.13K	-39.65K	1.2K
Investing Cash Flow	33.23M	-189.04M	-204.51M	1.42M	-180.89M	30.13M	-68.71M	-49.02M	10.34M	-16.66M	-16.07M	-39.72M	1.08K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-5.99K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	615K	-757K	-588.22K	702K	-18.37M	473K	-297K	-2.57M	-316K	-259K	31.04M	-1.45M	-115K
Financial Cash Flow	615K	-757K	514.01M	700.86K	281.97M	473K	-297K	169.73M	-316K	-259K	31.04M	-1.45M	-115
Net Cash Flow	-2.62M	-209.5M	283.81M	-31.96M	79.16M	10.04M	-85.9M	100.4M	-2M	-27.4M	4.87M	-54.68M	-9.79K
Free Cash Flow	-36.48M	-20.38M	-26.82M	-34.19M	-23.07M	-21.38M	-17.09M	-20.31M	-12.1M	-10.55M	-10.04M	-13.58M	-10.88K